JayaBio News
Jaya Biosciences: Neuroscience Startup Chosen for SCbioDrive Accelerator Program
Jaya Biosciences was highlighted in a press release by SCbio for our work in developing CNS-directed gene therapies for neurodegenerative diseases like Alzheimer’s, Parkinson’s, and frontotemporal dementia as we begin the inaugural SCbioDrive Accelerator Program.
Jaya Biosciences Has Been Selected for the Inaugural SCbioDrive Cohort of Highly Promising Oncology and Neuroscience Startups
This program will support our efforts to advance groundbreaking innovations in neurodegeneration alongside other exceptional early-stage companies.
Jaya Biosciences Presents Updated Preclinical Data in Alzheimer’s Disease at the 45th SIMD Annual Meeting
Study results confirm potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s disease
Jaya Biosciences Presents New Paradigm for the Treatment of Alzheimer’s Disease at the 23rd Annual Needham Virtual Healthcare Conference
Data presented highlight the potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s
Jaya Biosciences Presents Promising Preclinical Data in Alzheimer’s Disease at the 20th Annual WORLDSymposium™ 2024
Study results highlight potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s